A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF (1994) J Infect Dis 169: 68-76 Immune responses to pertussis vaccines and disease. Edwards KM, Berbers GA (2014) J Infect Dis 209 Suppl 1: S10-5 Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK, U.S. Flu-VE Network (2011) PLoS One 6: e23085 Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Neuzil KM, Dupont WD, Wright PF, Edwards KM (2001) Pediatr Infect Dis J 20: 733-40 Respiratory syncytial virus vaccine development. Crowe JE (2001) Vaccine 20 Suppl 1: S32-7 Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL, Pandemic H1N1 Vaccine Adult Study Group (2012) Vaccine 30: 4240-8 Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N (2014) Pediatr Blood Cancer 61: 815-20
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.